186 related articles for article (PubMed ID: 15883753)
1. Effect of sildenafil on reperfusion function, infarct size, and cyclic nucleotide levels in the isolated rat heart model.
du Toit EF; Rossouw E; Salie R; Opie LH; Lochner A
Cardiovasc Drugs Ther; 2005 Jan; 19(1):23-31. PubMed ID: 15883753
[TBL] [Abstract][Full Text] [Related]
2. Cardioprotection with sildenafil, a selective inhibitor of cyclic 3',5'-monophosphate-specific phosphodiesterase 5.
Das S; Maulik N; Das DK; Kadowitz PJ; Bivalacqua TJ
Drugs Exp Clin Res; 2002; 28(6):213-9. PubMed ID: 12776574
[TBL] [Abstract][Full Text] [Related]
3. Sildenafil citrate (viagra) induces cardioprotective effects after ischemia/reperfusion injury in infant rabbits.
Bremer YA; Salloum F; Ockaili R; Chou E; Moskowitz WB; Kukreja RC
Pediatr Res; 2005 Jan; 57(1):22-7. PubMed ID: 15531735
[TBL] [Abstract][Full Text] [Related]
4. Sildenafil and vardenafil but not nitroglycerin limit myocardial infarction through opening of mitochondrial K(ATP) channels when administered at reperfusion following ischemia in rabbits.
Salloum FN; Takenoshita Y; Ockaili RA; Daoud VP; Chou E; Yoshida K; Kukreja RC
J Mol Cell Cardiol; 2007 Feb; 42(2):453-8. PubMed ID: 17157308
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of ischaemic preconditioning in the eNOS overexpressed working mouse heart model.
du Toit EF; Genade S; Carlini S; Moolman JA; Brunner F; Lochner A
Eur J Pharmacol; 2007 Feb; 556(1-3):115-20. PubMed ID: 17157294
[TBL] [Abstract][Full Text] [Related]
6. Sildenafil reduces L-NAME-induced severe hypertension and worsening of myocardial ischaemia-reperfusion damage in the rat.
Rossoni G; Manfredi B; De Gennaro Colonna V; Berti M; Guazzi M; Berti F
Br J Pharmacol; 2007 Mar; 150(5):567-76. PubMed ID: 17245365
[TBL] [Abstract][Full Text] [Related]
7. B-type natriuretic peptide at early reperfusion limits infarct size in the rat isolated heart.
Burley DS; Baxter GF
Basic Res Cardiol; 2007 Nov; 102(6):529-41. PubMed ID: 17896117
[TBL] [Abstract][Full Text] [Related]
8. Tissue distribution of phosphodiesterase families and the effects of sildenafil on tissue cyclic nucleotides, platelet function, and the contractile responses of trabeculae carneae and aortic rings in vitro.
Wallis RM; Corbin JD; Francis SH; Ellis P
Am J Cardiol; 1999 Mar; 83(5A):3C-12C. PubMed ID: 10078537
[TBL] [Abstract][Full Text] [Related]
9. Vardenafil: a novel type 5 phosphodiesterase inhibitor reduces myocardial infarct size following ischemia/reperfusion injury via opening of mitochondrial K(ATP) channels in rabbits.
Salloum FN; Ockaili RA; Wittkamp M; Marwaha VR; Kukreja RC
J Mol Cell Cardiol; 2006 Mar; 40(3):405-11. PubMed ID: 16480739
[TBL] [Abstract][Full Text] [Related]
10. ERK phosphorylation mediates sildenafil-induced myocardial protection against ischemia-reperfusion injury in mice.
Das A; Salloum FN; Xi L; Rao YJ; Kukreja RC
Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1236-43. PubMed ID: 19286961
[TBL] [Abstract][Full Text] [Related]
11. Phosphodiesterase 5A inhibition induces Na+/H+ exchanger blockade and protection against myocardial infarction.
Pérez NG; Piaggio MR; Ennis IL; Garciarena CD; Morales C; Escudero EM; Cingolani OH; Chiappe de Cingolani G; Yang XP; Cingolani HE
Hypertension; 2007 May; 49(5):1095-103. PubMed ID: 17339532
[TBL] [Abstract][Full Text] [Related]
12. Cyclic nucleotide phosphodiesterase type 5 activity limits blood flow to hypoperfused myocardium during exercise.
Traverse JH; Chen YJ; Du R; Bache RJ
Circulation; 2000 Dec; 102(24):2997-3002. PubMed ID: 11113052
[TBL] [Abstract][Full Text] [Related]
13. Effect of nitrovasodilators and inhibitors of nitric oxide synthase on ischaemic and reperfusion function of rat isolated hearts.
du Toit EF; McCarthy J; Miyashiro J; Opie LH; Brunner F
Br J Pharmacol; 1998 Mar; 123(6):1159-67. PubMed ID: 9559900
[TBL] [Abstract][Full Text] [Related]
14. Maximizing the renal cyclic 3'-5'-guanosine monophosphate system with type V phosphodiesterase inhibition and exogenous natriuretic peptide: a novel strategy to improve renal function in experimental overt heart failure.
Chen HH; Huntley BK; Schirger JA; Cataliotti A; Burnett JC
J Am Soc Nephrol; 2006 Oct; 17(10):2742-7. PubMed ID: 16928803
[TBL] [Abstract][Full Text] [Related]
15. Effects of the cardioselective KATP channel blocker HMR 1098 on cardiac function in isolated perfused working rat hearts and in anesthetized rats during ischemia and reperfusion.
Gögelein H; Ruetten H; Albus U; Englert HC; Busch AE
Naunyn Schmiedebergs Arch Pharmacol; 2001 Jul; 364(1):33-41. PubMed ID: 11485036
[TBL] [Abstract][Full Text] [Related]
16. Enhanced cardioprotection against ischemia-reperfusion injury with combining sildenafil with low-dose atorvastatin.
Rosanio S; Ye Y; Atar S; Rahman AM; Freeberg SY; Huang MH; Uretsky BF; Birnbaum Y
Cardiovasc Drugs Ther; 2006 Feb; 20(1):27-36. PubMed ID: 16435070
[TBL] [Abstract][Full Text] [Related]
17. Effects of sildenafil on myocardial infarct size, microvascular function, and acute ischemic left ventricular dilation.
Reffelmann T; Kloner RA
Cardiovasc Res; 2003 Aug; 59(2):441-9. PubMed ID: 12909327
[TBL] [Abstract][Full Text] [Related]
18. Impact of Mitochondrial Ca2+-Sensitive Potassium (mBKCa) Channels in Sildenafil-Induced Cardioprotection in Rats.
Behmenburg F; Dorsch M; Huhn R; Mally D; Heinen A; Hollmann MW; Berger MM
PLoS One; 2015; 10(12):e0144737. PubMed ID: 26671662
[TBL] [Abstract][Full Text] [Related]
19. Sildenafil reduces cardiovascular remodeling associated with hypertensive cardiomyopathy in NOS inhibitor-treated rats.
Ferreira-Melo SE; Yugar-Toledo JC; Coelho OR; De Luca IM; Tanus-Santos JE; Hyslop S; Irigoyen MC; Moreno H
Eur J Pharmacol; 2006 Aug; 542(1-3):141-7. PubMed ID: 16806160
[TBL] [Abstract][Full Text] [Related]
20. Effect of sildenafil on coronary active and reactive hyperemia.
Chen Y; Du R; Traverse JH; Bache RJ
Am J Physiol Heart Circ Physiol; 2000 Nov; 279(5):H2319-25. PubMed ID: 11045968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
